GlassScriptPhysician profile
Tracey R Lemon
NPI 1881658201
$36,333.29
in general payments reported to CMS, 2019-2025
18 companies · $520 in 2025
The $520 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $137 · 2021: $168 · 2022: $87.35 · 2023: $318 · 2024: $95.55 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.74 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $34,603.58 | 2019-2021 | |
| Abbvie INC. | $397.16 | 2019-2022 | |
| Astellas Pharma US INC | $222.08 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $156.07 | 2019-2023 | Slynd |
| Lilly USA, LLC | $155.61 | 2025 | Zepbound, Mounjaro |
| Daiichi Sankyo INC. | $126.98 | 2019-2021 | |
| Viiv Healthcare Company | $110.88 | 2025 | Apretude |
| Optumhealth Care Solutions, LLC | $106.71 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Acessa Health INC. | $69.16 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.89 | 2025 | |
| Sumitomo Pharma America, INC. | $59.37 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $58.69 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $47.20 | 2019-2020 | |
| Hologic Sales and Service, LLC | $44.43 | 2024 | Acessa Provu System |
| Convatec INC. | $41.56 | 2020-2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $37.55 | 2019 | |
| Gilead Sciences, INC. | $17.70 | 2019 | |
| Baxter Healthcare | $17.67 | 2023 | Tisseel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Lemon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.